A Stable Aberrant Immunophenotype Characterizes Nearly All Cases of Cutaneous T-cell Lymphoma in Blood and Can Be Used to Monitor Response to Therapy

Overview

Journal BMC Clin Pathol

Publisher Biomed Central

Date 2002 Dec 12

PMID 12475398

Citations 7

Authors

LaBaron T Washington

Yang O Huh

Linda C Powers

Madeleine Duvic

Dan Jones

Affiliations

Soon will be listed here.

Abstract

BACKGROUND: Abnormal variations in the expression level of some commonly expressed T-cell antigens are a feature of many T-cell malignancies. METHODS: We sought to assess the frequency of such abnormal antigen expression by flow cytometry in peripheral blood (PB) samples from patients with mycosis fungoides (MF) and Sézary syndrome (SS). We correlated presence of morphologically identifiable tumor cells on PB smear with the frequency of abnormalities in the level of expression of CD3, CD4, CD7, CD8 and CD26. We also examined the degree of stability of these abnormal findings in tumor cells over the course of disease. The flow cytometric findings in 100 PB samples from 44 patients, including 38 who had multiple sequential PB samples (2-8 samples each), were assessed. RESULTS: Abnormalities were seen in the expression level of one or more T-cell markers in 41 cases (93%) including CD3 in 34% of patients, CD4 in 54%, CD26 in 86% and CD 45 in 40% (10 cases tested). In all but 2 cases, the abnormal T-cell immunophenotype remained similar over the course of treatment and correlated with the relative numbers of tumor cells counted on PB smear. CONCLUSIONS: Using a standard T-cell panel, stable phenotypically aberrant T-cell populations representing the tumor are detected in the vast majority of involved PB samples in MF/SS and can be used to monitor response to therapy.

Citing Articles

CCL27 Signaling in the Tumor Microenvironment.

Martinez-Rodriguez M, Monteagudo C Adv Exp Med Biol. 2021; 1302:113-132.

PMID: 34286445 DOI: 10.1007/978-3-030-62658-7_9.

Two cases of phenotypic switch of primary cutaneous T cell lymphoma after treatment with an aggressive course and review of the literature.

Marks E, Shi Y, Wang Y Virchows Arch. 2019; 475(5):637-648.

PMID: 31218405 DOI: 10.1007/s00428-019-02599-5.

Increased Twist expression in advanced stage of mycosis fungoides and Sézary syndrome.

Goswami M, Duvic M, Dougherty A, Ni X J Cutan Pathol. 2012; 39(5):500-7.

PMID: 22515221 PMC: 3796850. DOI: 10.1111/j.1600-0560.2012.01883.x.

High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.

Clark R, Shackelton J, Watanabe R, Calarese A, Yamanaka K, Campbell J Blood. 2010; 117(6):1966-76.

PMID: 21148332 PMC: 3056643. DOI: 10.1182/blood-2010-05-287664.

The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome.

Scala E, Abeni D, Pomponi D, Narducci M, Lombardo G, Mari A Haematologica. 2010; 95(11):1905-12.

PMID: 20663947 PMC: 2966913. DOI: 10.3324/haematol.2010.026260.

References

Kukel S, Reinhold U, Oltermann I, Kreysel H . Progressive increase of CD7- T cells in human blood lymphocytes with ageing. Clin Exp Immunol. 1994; 98(1):163-8. PMC: 1534167. DOI: 10.1111/j.1365-2249.1994.tb06624.x. View

Volarevic S, Niklinska B, Burns C, Yamada H, June C, Dumont F . The CD45 tyrosine phosphatase regulates phosphotyrosine homeostasis and its loss reveals a novel pattern of late T cell receptor-induced Ca2+ oscillations. J Exp Med. 1992; 176(3):835-44. PMC: 2119358. DOI: 10.1084/jem.176.3.835. View

Lambeir A, Proost P, Durinx C, Bal G, Senten K, Augustyns K . Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family. J Biol Chem. 2001; 276(32):29839-45. DOI: 10.1074/jbc.M103106200. View

Delfau-Larue M, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-Bonnet M . Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood. 2000; 96(9):2987-92. View

Moll M, Reinhold U, Kukel S, Abken H, Muller R, Oltermann I . CD7-negative helper T cells accumulate in inflammatory skin lesions. J Invest Dermatol. 1994; 102(3):328-32. DOI: 10.1111/1523-1747.ep12371791. View

Dummer R, Nestle F, Niederer E, Ludwig E, Laine E, Grundmann H . Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome. Arch Dermatol Res. 1999; 291(6):307-11. DOI: 10.1007/s004030050414. View

Edelman J, Meyerson H . Diminished CD3 expression is useful for detecting and enumerating Sézary cells. Am J Clin Pathol. 2000; 114(3):467-77. DOI: 10.1093/ajcp/114.3.467. View

Rappl G, Muche J, Abken H, Sterry W, Tilgen W, Ugurel S . CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol. 2001; 44(3):456-61. DOI: 10.1067/mjd.2001.110900. View

Hastrup N, Ralfkiaer E, Pallesen G . Aberrant phenotypes in peripheral T cell lymphomas. J Clin Pathol. 1989; 42(4):398-402. PMC: 1141912. DOI: 10.1136/jcp.42.4.398. View

10.

Vignali D, Carson R, Chang B, Mittler R, Strominger J . The two membrane proximal domains of CD4 interact with the T cell receptor. J Exp Med. 1996; 183(5):2097-107. PMC: 2192586. DOI: 10.1084/jem.183.5.2097. View

11.

Vega F, Luthra R, Medeiros L, Dunmire V, Lee S, Duvic M . Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood. 2002; 100(9):3369-73. DOI: 10.1182/blood.V100.9.3369. View

12.

Wood K, Pallesen G, Ralfkiaer E, Warnke R, Gatter K, Mason D . Heterogeneity of CD3 antigen expression in T-cell lymphoma. Histopathology. 1993; 22(4):311-7. DOI: 10.1111/j.1365-2559.1993.tb00129.x. View

13.

Ikushima H, Munakata Y, Ishii T, Iwata S, Terashima M, Tanaka H . Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation. Proc Natl Acad Sci U S A. 2000; 97(15):8439-44. PMC: 26966. DOI: 10.1073/pnas.97.15.8439. View

14.

Ludwig A, Schiemann F, Mentlein R, Lindner B, Brandt E . Dipeptidyl peptidase IV (CD26) on T cells cleaves the CXC chemokine CXCL11 (I-TAC) and abolishes the stimulating but not the desensitizing potential of the chemokine. J Leukoc Biol. 2002; 72(1):183-91. View

15.

Ginaldi L, Matutes E, Farahat N, De Martinis M, Morilla R, Catovsky D . Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry. Br J Haematol. 1996; 93(4):921-7. DOI: 10.1046/j.1365-2141.1996.d01-1720.x. View

16.

Reinhold U, Liu L, Sesterhenn J, Abken H . CD7-negative T cells represent a separate differentiation pathway in a subset of post-thymic helper T cells. Immunology. 1996; 89(3):391-6. PMC: 1456566. DOI: 10.1046/j.1365-2567.1996.d01-744.x. View

17.

Bernengo M, Novelli M, Quaglino P, Lisa F, De Matteis A, Savoia P . The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. Br J Dermatol. 2001; 144(1):125-35. DOI: 10.1046/j.1365-2133.2001.04014.x. View

18.

Schmidt C, Przybylski G, Seeger K, Siegert W . TCR delta gene rearrangements in acute myeloid leukemia with T-lymphoid antigen expression. Leuk Lymphoma. 1995; 20(1-2):45-9. DOI: 10.3109/10428199509054752. View

19.

Jones D, Dorfman D . Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma. Leuk Lymphoma. 2001; 40(5-6):449-59. DOI: 10.3109/10428190109097644. View

20.

Jones D, Dang N, Duvic M, Washington L, Huh Y . Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am J Clin Pathol. 2001; 115(6):885-92. DOI: 10.1309/U1Y6-J4AG-5M4M-7AYV. View